Re: Postmarking adverse events related to sotradecol (sodium tetradecyl sulfate-sclerosing agent).
Bonnel
Renan A
RA
D016907:Adverse Drug Reaction Reporting Systems; D006801:Humans; D010538:Peritonitis / Q000209:etiology*; D011358:Product Surveillance, Postmarketing; D012597:Sclerosing Solutions / Q000009:adverse effects*; D012981:Sodium Tetradecyl Sulfate / Q000009:adverse effects*; D014481:United States; D014486:United States Food and Drug Administration
D012597:Sclerosing Solutions; D012981:Sodium Tetradecyl Sulfate